 |
|
|
|
|
Indiana Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing IndianaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
ImmuneWorks
| | | | | Phone: | (317) 278-0205 | | Year Established: | 2006 | | Main Contact: | Wade Lange, President & CEO | | | | Other Contacts: | Terrence Chew, MD, Head of Clinical and Regulatory Development
Katia Rothhaar, Ph.D., Director of Research Operations
Michael Klemsz, Ph.D., Co-Founder & VP, Research
David Wilkes, MD, Co-Founder & CSO
| | | | Company Description | | ImmuneWorks is a clinical stage biotechnology company developing a therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. Over 200,000 patients in the US and Top 5 EU countries are afflicted with IPF, a deadly disease with a 5-year mortality rate of 50 – 70 percent. | |
|
|
|
|
|
|
|
